The United States announced on Monday that it had reached an agreement with the United Kingdom to exempt pharmaceutical products and medical technology from customs duties. This agreement will, in turn, lead to an increase in UK spending on drugs. The agreement includes an increase in the share of the budget of the National Health Service, which is state-managed and allocated for drug spending.
US and UK Reach Deal to Eliminate Drug Tariffs
The US and UK have agreed to eliminate customs duties on pharmaceutical products and medical technology, which will lead to increased drug spending in the UK.
